of the Viewers Choice Award at the Enterprise Ireland BIG IDEAS 2022
INFUSION SETS NEED TO BE FREQUENTLY CHANGED
For people with type 1 diabetes, getting life saving insulin into their body is a lot of work. The development of insulin pump technologies has rapidly evolved over the last 50 years, however, the most important component of this system; infusion sets, have not. Infusion sets have a lifespan of 2 or 3 days and frequently fail within hours of insertion. The short lifespan and high failure rates cause more interruptions to insulin therapy, which are shown to negatively impact blood-glucose control.
Failed cannulas and the insulin discarded within them are also a waste that leads to excessive environmental impact and excessive healthcare spending.
People living with type 1 diabetes (T1D) worldwide
Use Insulin pumps. Low adoption due to unreliability of infusion sets
of users change their infusion set early due to kinking or blocking
of people with T1D would use insulin pumps if infusion sets were more reliable
Fada Medical's mission is to optimize chronic drug therapy, making life easier for the people who need it. Starting with insulin delivery for those with type 1 diabetes, Fada Medical are developing soft robotic active diffusion technologies to prevent and negate the causes of early infusion set failure and cannula occlusion that make insulin therapy more difficult.
Raising the Bar
IMPROVED CONSISTENCY OF INSULIN DELIVERY
RESISTANT TO SILENT OCCLUSION
MEET THE TEAM
PROF. GARRY DUFFY
DR. EIMEAR DOLAN
PROF ELLEN ROCHE
PROF DEREK O'KEEFFE
Our technology will have an impact on insulin therapy in a number of different ways:
Better glucose control
Longer lifespan and consistency
Reduced patient burden
Improve patient long term outcomes
Eliminate €1billion waste in healthcare industry
Reduce patient hospitalisations
GET IN TOUCH
We’re always happy to hear from you. Contact us today to learn more about our business.